Source: International Congress 2015 – IIPs: orphan
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yoshikazu Inoue (Osaka, Japan), Yoshikazu Inoue, Masaki Hirose, Toru Arai, Chikatoshi Sugimoto, Akiko Matsumuro, Tomomi Homma, Yoshinobu Matsuda, Aya Hirooka, Naoko Takeuchi, Yumiko Sasaki, Kazunobu Tachibana, Seiji Hayashi, Masanori Akira, Masanori Kitaichi. Serum angiotensin-converting enzyme activity in lymphangioleiomyomatosis. Eur Respir J 2015; 46: Suppl. 59, 3814

Member's Comments

No comment yet.

Related content which might interest you: Erdheim-Chester disease: Patterns and pulmonary involvement Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Biomarkers in sarcoidois follow-up: Angiotensin-converting enzyme or chitotriosidase? Source: International Congress 2014 – Sarcoidosis Year: 2014 Lymphangioma in patients with pulmonary lymphangioleiomyomatosis – Results of sirolimus treatment Source: International Congress 2016 – Orphan diseases I Year: 2016 Childhood interstitial lung disease: A diagnostic challenge Source: International Congress 2015 – Connective tissue disorders Year: 2015 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Seasonal variation of serum KL-6 levels in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 1 Year: 2014 ACE and sIL2-R predict lung function improvement in sarcoidosis during methotrexate therapy Source: Annual Congress 2013 –Sarcoidosis Year: 2013 The clinical features of 13 patients with interstitial pneumonia with positive anti-glycyl-tRNA synthetase autoantibodies Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy Source: International Congress 2014 – ILDs 4 Year: 2014 The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Genetic testing in idiopathic interstitial pneumonia Source: International Congress 2015 – New insights into IIPs Year: 2015 Steroid treatment effect in pulmonary sarcoidosis (STEPS study) Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up? Source: International Congress 2016 – Connective tissue disorders Year: 2016 The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in patients with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Elevation of serum napsin A levels in patients with hypersensitive pneumonia Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015